Regulator says it has not started reviewing Sinopharm application bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.
COVID-19 Vaccination Syringes Prepared & Distributed by RAMM Pharma
TORONTO RAMM Pharma Corp., a cannabinoid pharmaceutical products company, announces that the Uruguayan Ministry of Public Health, (Ministerio de Salúd Publica or “MSP”) has selected RAMM as a fulfilment and distribution partner for Uruguay’s COVID-19 vaccination program. Under the arrangement, RAMM will be responsible for the sterilization, packaging and distribution of syringes and other medical supplies for use in the country’s COVID-19 vaccination program. RAMM’s GMP certified pharmaceutical facility was selected for the program upon satisfaction of the requirements of the Ministry of Public Health.
“We are pleased to play an integral role in Uruguay’s COVID-19 vaccination effort. Our selection by the Ministry of Public Health is a testament to our longstanding relationship and recognition of the specialized capabilities of our team and GMP facility within the pharmaceutical community,” stated
RAMM Pharma Selected as COVID-19 Vaccine Fulfilment & Distribution Partner by the Uruguayan Ministry of Health morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
ADVANZ Pharma Corp. Limited - Update on Formal Sale Process
PR Newswire
London, January 21
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION
THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER WILL BE MADE
21 January 2021
Update on Formal Sale Process
Canapar Welcomes RAMM Pharma as Strategic Shareholder; Closes $6,427,000 Financing
January 20, 2021 09:48 ET | Source: Canapar Corp. Canapar Corp. Toronto, Ontario, CANADA
RAGUSA, Italy, Jan. 20, 2021 (GLOBE NEWSWIRE) Canapar Corp. (“Canapar”) and RAMM Pharma Corp. (including its wholly owned subsidiaries, RAMM ) (CSE: RAMM) are pleased to announce they have entered into a strategic partnership, combining Canapar’s hemp-derived cannabidiol (CBD) extraction expertise with RAMM’s leadership in cannabis-derived pharmaceutical and cosmeceutical products. As part of the strategic partnership, RAMM has acquired Canopy Rivers’ (TSX: RIV) (OTC: CNPOF) 49% ownership interest in Canapar. This investment is expected to immediately enhance both RAMM and Canapar’s ability to capitalize on the rapidly expanding European and South American hemp-derived CBD markets.